Physiology of Telocytes

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 30 April 2025 | Viewed by 1913

Special Issue Editors


E-Mail Website
Guest Editor
1. Laboratory of Ultrastructural Pathology, “Victor Babeș” National Institute of Pathology, 050096 Bucharest, Romania
2. Division of Cellular and Molecular Biology & Histology, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania
Interests: dermatology; skin regeneration/repair; regenerative medicine; telocytes

E-Mail Website
Guest Editor
1. Division of Cellular and Molecular Biology & Histology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania
2. "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania
Interests: prognostic markers; cancer biomarkers; cancer biology; cancer metastasis; metastasis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Some will say that the best things happen unexpectedly …

The scientific quest of Telocytes started in Bucharest, in early 2005, as a delightful research-based endeavor into describing the microscopic environment of pancreas interstitum, at that time focusing on the Cajal’s so-called “interstitial neurons'' (Interstitial Cells of Cajal, ICC). However, in pancreatic stroma, among the well-acknowledged ICC, we extensively described cells with morphological similarities, but distinctive, suggesting for that moment the name of Interstitial Cajal-like cells (ICLC). Moreover, at that time, our extended research evidenced the pervasive existence of the so-called ICLC into interstitia of many other organs (cavitary or non-cavitary) strongly suggesting their ubiquity. Shortly, all that research was internationally confirmed, and additional complementary data was published in support of the existence of this cell population within already acknowledged organs. Considering that sometimes evidence is stronger than just indicating a few coincidences, by summarizing the ultrastructural details of both cell types one conclusion resided: there is a reasonable difference between ICC and ICLC and this is driving an imperious necessity of delimiting these cell populations. Moreover, this was carried out by terming ICLC as Telocytes (lat. Tλoσ (Telos)— individual’s greatest potential). 

Presently, Telocytes represent a distinct interstitial cell population, extensively documented in terms of morphology and microscopical evidence, whose described interstitial distribution spectrum has been significantly expanded in recent years. To date, there is a great body of data referring to the existence of Telocytes within different organ interstitia of various animal species (mammals, amphibians, reptiles, etc.), reported at distinct stages of evolution. These findings are somehow indicating the evolutionary involvement of Telocytes into the definition of tissular architecture and tissular homeostatic processes of different species, including humans. Additionally, to all this valuable microscopy data other strong genetical, biochemical, proteomic and immunohistochemical evidence were published, favoring few hypotheses related to Telocytes roles either in normal tissue, or in various pathologies. The involvement of interstitium into specific pathologies was previously studied and the targeted (ultra)structural changes of Telocytes could still indicate apparent features of this distinct interstitial cell population. However, a few crucial questions are still standing, like: What is their distinctive cell marker(s)? Which are those exact role(s) of Telocytes? How can Telocytes be leveraged for scientific and medical purposes?

We presume that the first natural and logical steps into elucidating the roles of Telocytes were (at least partially) accomplished. In this context we are considering, organizing, and proposing you this Special Issue on Physiology of Telocytes as a step forward in clarifying and attesting the roles of Telocytes, and bring evidence of their distinct physiology in relation with their peculiar microscopic morphology. Here, we are encouraging publishing new data on Telocytes that could help in elucidating their functionality into the living interstitium, or could help clarify their definitive roles either in lesion progression, or in tissue homeostasis.

However, this is just the beginning of a thrilling scientific journey of which destination could offer (at least a few) new medical approaches, or, in the finals, could participate in changes of some medical paradigms. 

We are looking forward to receiving your manuscripts.

Dr. Catalin G. Manole
Prof. Dr. Mihail E. Hinescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • telocytes
  • telopodes
  • physiology
  • pathology
  • tissue homeostasis
  • regenerative medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

41 pages, 24938 KiB  
Review
Skin Telocytes Could Fundament the Cellular Mechanisms of Wound Healing in Platelet-Rich Plasma Administration
by Catalin G. Manole, Vlad M. Voiculescu, Cristina Soare, Laura Cristina Ceafalan, Mihaela Gherghiceanu and Mihail E. Hinescu
Cells 2024, 13(16), 1321; https://doi.org/10.3390/cells13161321 - 8 Aug 2024
Viewed by 1479
Abstract
For more than 40 years, autologous platelet concentrates have been used in clinical medicine. Since the first formula used, namely platelet-rich plasma (PRP), other platelet concentrates have been experimented with, including platelet-rich fibrin and concentrated growth factor. Platelet concentrates have three standard characteristics: [...] Read more.
For more than 40 years, autologous platelet concentrates have been used in clinical medicine. Since the first formula used, namely platelet-rich plasma (PRP), other platelet concentrates have been experimented with, including platelet-rich fibrin and concentrated growth factor. Platelet concentrates have three standard characteristics: they act as scaffolds, they serve as a source of growth factors and cytokines, and they contain live cells. PRP has become extensively used in regenerative medicine for the successful treatment of a variety of clinical (non-)dermatological conditions like alopecies, acne scars, skin burns, skin ulcers, muscle, cartilage, and bone repair, and as an adjuvant in post-surgery wound healing, with obvious benefits in terms of functionality and aesthetic recovery of affected tissues/organs. These indications were well documented, and a large amount of evidence has already been published supporting the efficacy of this method. The primordial principle behind minimally invasive PRP treatments is the usage of the patient’s own platelets. The benefits of the autologous transplantation of thrombocytes are significant, representing a fast and economic method that requires only basic equipment and training, and it is biocompatible, thus being a low risk for the patient (infection and immunological reactions can be virtually disregarded). Usually, the structural benefits of applying PRP are attributed to fibroblasts only, as they are considered the most numerous cell population within the interstitium. However, this apparent simplistic explanation is still eluding those different types of interstitial cells (distinct from fibroblasts) that are residing within stromal tissue, e.g., telocytes (TCs). Moreover, dermal TCs have an already documented potential in angiogenesis (extra-cutaneous, but also within skin), and their implication in skin recovery in a few dermatological conditions was attested and described ultrastructurally and immunophenotypically. Interestingly, PRP biochemically consists of a series of growth factors, cytokines, and other molecules, to which TCs have also proven to have a positive expression. Thus, it is attractive to hypothesize and to document any tissular collaboration between cutaneous administered PRP and local dermal TCs in skin recovery/repair/regeneration. Therefore, TCs could be perceived as the missing link necessary to provide a solid explanation of the good results achieved by administering PRP in skin-repairing processes. Full article
(This article belongs to the Special Issue Physiology of Telocytes)
Show Figures

Graphical abstract

Back to TopTop